Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background: Metabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones increasingly track physiological and lifestyle risk factors and can improve the management of metabolic diseases. However, the absence of clear guidelines for deriving meaningful signals from these devices often hampers cross-study comparisons. Objective: Thus, this scoping review protocol aims to systematically overview the current empirical literature on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases. Methods: We will conduct a scoping review to overview how wearables and smartphones measure modifiable risk factors related to metabolic diseases. We will search six databases (Scopus, Web of Science, ScienceDirect, PubMed, ACM Digital Library, and IEEE Xplore) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. We will apply the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and Arksey and O'Malley's scoping review methodology. Eligible studies will use smartphones and/or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological and/or lifestyle factors related to metabolic diseases. Two reviewers will independently screen articles for inclusion. Data will be extracted using a standardized form, and the findings will be synthesized and reported qualitatively and quantitatively. Results: The study is expected to identify potential gaps in measuring modifiable risk factors in current digital metabolic health research. Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements to aid cross-study comparison. The final report is planned for submission to an indexed journal. Conclusions: This review is among the first to systematically overview the current landscape on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases.
Background: Metabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones increasingly track physiological and lifestyle risk factors and can improve the management of metabolic diseases. However, the absence of clear guidelines for deriving meaningful signals from these devices often hampers cross-study comparisons. Objective: Thus, this scoping review protocol aims to systematically overview the current empirical literature on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases. Methods: We will conduct a scoping review to overview how wearables and smartphones measure modifiable risk factors related to metabolic diseases. We will search six databases (Scopus, Web of Science, ScienceDirect, PubMed, ACM Digital Library, and IEEE Xplore) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. We will apply the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) and Arksey and O'Malley's scoping review methodology. Eligible studies will use smartphones and/or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological and/or lifestyle factors related to metabolic diseases. Two reviewers will independently screen articles for inclusion. Data will be extracted using a standardized form, and the findings will be synthesized and reported qualitatively and quantitatively. Results: The study is expected to identify potential gaps in measuring modifiable risk factors in current digital metabolic health research. Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements to aid cross-study comparison. The final report is planned for submission to an indexed journal. Conclusions: This review is among the first to systematically overview the current landscape on how wearables and smartphones are used to measure modifiable risk factors associated with metabolic diseases.
Elevated postprandial glucose levels pose a global epidemic and are crucial in cardiometabolic disease management and prevention. A major challenge is inter-individual variability, which limits the effectiveness of population-wide dietary interventions. To develop personalized interventions, it is critical to first predict a person’s vulnerability to postprandial glucose excursions—or elevated post-meal glucose relative to a personal baseline—with minimal burden. We examined the feasibility of personalized models to predict future glucose excursions in the daily lives of 69 Chinese adults with type-2 diabetes (Mage=61.5; 50% women; 2’595 glucose observations). We developed machine learning models, trained on past individual context and meal-based observations, employing low-burden (continuous glucose monitoring) or additional high-burden (manual meal tracking) approaches. Personalized models predicted glucose excursions (F1-score:M=74%; median=78%), with some individuals being more predictable than others. The low burden-models performed better for those with consistent meal patterns and healthier glycemic profiles. Notably, no two individuals shared the same meal and context-based vulnerability predictors. This study is the first to predict individual vulnerability to glucose excursions among a sample of Chinese adults with type-2 diabetes. Findings can help personalize just-in-time-adaptive dietary interventions to unique vulnerability to glucose excursions in daily live, thereby helping improve diabetes management.
Background Metabolic diseases, such as cardiovascular diseases and diabetes, contribute significantly to global mortality and disability. Wearable devices and smartphones are increasingly used to track and manage modifiable risk factors associated with metabolic diseases. However, no established guidelines exist on how to derive meaningful signals from these devices, often hampering cross-study comparisons. Objective This study aims to systematically overview the current empirical literature on how wearables and smartphones are used to track modifiable (physiological and lifestyle) risk factors associated with metabolic diseases. Methods We will conduct a scoping review to overview how wearable and smartphone-based studies measure modifiable risk factors related to metabolic diseases. We will search 5 databases (Scopus, Web of Science, PubMed, Cochrane Central Register of Controlled Trials, and SPORTDiscus) from 2019 to 2024, with search terms related to wearables, smartphones, and modifiable risk factors associated with metabolic diseases. Eligible studies will use smartphones or wearables (worn on the wrist, finger, arm, hip, and chest) to track physiological or lifestyle factors related to metabolic diseases. We will follow the reporting guideline standards from PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) and the JBI (Joanna Briggs Institute) guidance on scoping review methodology. Two reviewers will independently screen articles for inclusion and extract data using a standardized form. The findings will be synthesized and reported qualitatively and quantitatively. Results Data collection is expected to begin in November 2024; data analysis in the first quarter of 2025; and submission to a peer-reviewed journal by the second quarter of 2025. We expect to identify the degree to which wearable and smartphone-based studies track modifiable risk factors collectively (versus in isolation), and the consistency and variation in how modifiable risk factors are measured across existing studies. Conclusions Results are expected to inform more standardized guidelines on wearable and smartphone-based measurements, with the goal of aiding cross-study comparison. The final report is planned for submission to a peer-reviewed, indexed journal. This review is among the first to systematically overview the current landscape on how wearables and smartphones measure modifiable risk factors associated with metabolic diseases. International Registered Report Identifier (IRRID) PRR1-10.2196/59539
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.